Literature DB >> 17326893

Efficacy of topical ophthalmic prophylaxis in prevention of ophthalmia neonatorum.

Zahra Khalili Matinzadeh1, Fatemeh Beiragdar, Zohreh Kavemanesh, Hasan Abolgasemi, Susan Amirsalari.   

Abstract

Ophthalmia neonatorum is a form of conjunctivitis occurring in infants younger than 4 weeks. It can be a leading cause of blindness in newborns. In this random clinical case-control study, ophthalmia neonatorum was investigated in one university centre. In this study, prophylactic effect of normal saline and ophthalmic erythromycin was compared with a group not receiving any prophylaxis. The first group received ophthalmic erythromycin ointment (0.5%), the second group were distilled one drop of normal saline into each eye, and the third group did not take any prophylaxis. Within the first 10 days of life, conjunctivitis developed in 138 newborns (13.8%). Of conjunctivitis cases, 29.7% were in erythromycin group, 31.9% in normal saline group and 38.4% were in no-prophylaxis group. In general, no significant difference was observed among the three groups (P > 0.05).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326893     DOI: 10.1258/004947507779951880

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  Risk factors for neonatal conjunctivitis in babies of HIV-1 infected mothers.

Authors:  Stephen Gichuhi; Rose Bosire; Dorothy Mbori-Ngacha; Christine Gichuhi; Dalton Wamalwa; Elizabeth Maleche-Obimbo; Carey Farquhar; Grace Wariua; Phelgona Otieno; Grace C John-Stewart
Journal:  Ophthalmic Epidemiol       Date:  2009 Nov-Dec       Impact factor: 1.648

2.  Interventions for preventing ophthalmia neonatorum.

Authors:  Vimal Scott Kapoor; Jennifer R Evans; S Swaroop Vedula
Journal:  Cochrane Database Syst Rev       Date:  2020-09-21

3.  Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns.

Authors:  Tamar A Smith-Norowitz; Crystal Ukaegbu; Stephan Kohlhoff; Margaret R Hammerschlag
Journal:  BMC Infect Dis       Date:  2021-03-17       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.